Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C Betts

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|August 17, 2019
Editorial: Pathogenesis and Therapy of Graft-versus-Host DiseaseBrian C Betts, Xue-Zhong Yu
Blood|December 4, 2010
Tregs served sunny-side upBrian C Betts, James W Young
Blood Advances|February 13, 2026
Brute force: the effects of ibrutinib on brexu-celChelsea E Peterson, Brian C Betts
Critical Care Explorations|July 23, 2020
Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019Brian C Betts, James W Young
Blood Advances|February 24, 2026
Brute force: the effects of ibrutinib on brexu-celChelsea E Peterson, Brian C Betts
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 10, 2018
Reprint of: Emerging Therapeutics for the Control of Chronic Graft-versus-Host DiseaseKelli P A MacDonald, Brian C Betts, Daniel Couriel
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Emerging Therapeutics for the Control of Chronic Graft-versus-Host DiseaseKelli P A MacDonald, Brian C Betts, Daniel Couriel
Frontiers in Immunology|May 30, 2019
The IL-12 Cytokine and Receptor Family in Graft-vs.-Host DiseaseDavid Bastian, Yongxia Wu, Brian C Betts, et al.
Blood|September 24, 2011
Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responsesBrian C Betts, Erin T St Angelo, Michael Kennedy, et al.
Journal of Leukocyte Biology|September 27, 2013
STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacityBrian C Betts, Anandharaman Veerapathran, Joseph Pidala, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|August 17, 2019
Editorial: Pathogenesis and Therapy of Graft-versus-Host DiseaseBrian C Betts, Xue-Zhong Yu
Blood|December 4, 2010
Tregs served sunny-side upBrian C Betts, James W Young
Blood Advances|February 13, 2026
Brute force: the effects of ibrutinib on brexu-celChelsea E Peterson, Brian C Betts
Critical Care Explorations|July 23, 2020
Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019Brian C Betts, James W Young
Blood Advances|February 24, 2026
Brute force: the effects of ibrutinib on brexu-celChelsea E Peterson, Brian C Betts
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 10, 2018
Reprint of: Emerging Therapeutics for the Control of Chronic Graft-versus-Host DiseaseKelli P A MacDonald, Brian C Betts, Daniel Couriel
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Emerging Therapeutics for the Control of Chronic Graft-versus-Host DiseaseKelli P A MacDonald, Brian C Betts, Daniel Couriel
Frontiers in Immunology|May 30, 2019
The IL-12 Cytokine and Receptor Family in Graft-vs.-Host DiseaseDavid Bastian, Yongxia Wu, Brian C Betts, et al.
Blood|September 24, 2011
Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responsesBrian C Betts, Erin T St Angelo, Michael Kennedy, et al.
Journal of Leukocyte Biology|September 27, 2013
STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacityBrian C Betts, Anandharaman Veerapathran, Joseph Pidala, et al.
Pageof 6